Moleculin Biotech, Inc. (MBRX) (CIK 0001659617) UPLOAD
An UPLOAD letter is the SEC's written comment to the company during a filing review. SEC staff flag accounting issues, ICFR weaknesses, segment-reporting disputes, and revenue-recognition concerns here. Released to EDGAR 20 days after the SEC closes its review.
Key facts
- Accession number
- 0000000000-25-010407
- Form
- UPLOAD
- Filer
- Moleculin Biotech, Inc. (MBRX) (CIK 0001659617)
- CIK
- 0001659617
- Ticker
- MBRX
- Filed
- 2025-09-24
- SEC file number
- 333-290418
- SIC industry
- 2834
- HQ
- Houston, TX
Primary source
PDF letter: https://www.sec.gov/Archives/edgar/data/1659617/000000000025010407/filename1.pdf
EDGAR review index: browse all UPLOAD/CORRESP for this filer ↗
Other comment-letter activity for this filer